跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abilify Discmelt - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abilify Discmelt
Approved
STANDARD
Abilify Discmelt
Korea Otsuka Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
97a0a7656183f47f
Company
Korea Otsuka Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
97a0a7656183f47f
Drug Approval Philippines Name
Abilify Discmelt
Product Name
Abilify Discmelt
Registration Number
DR-XY45588
Brand Name
Abilify Discmelt
Generic Name
Aripiprazole
Dosage Form
Orally Disintegrating Tablet
Dosage Strength
10mg
Manufacturer
Korea Otsuka Pharmaceutical Co., Ltd.
Importer
Otsuka (Phils.) Pharmaceutical, Inc.
Distributor
Otsuka (Phils.) Pharmaceutical, Inc.
Company Detail Path
/organization/korea-otsuka-pharmaceutical-co-ltd
Issuance Date
27 May 2022
Expiry Date
06 September 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
97a0a7656183f47f
Type
Standard
Back to Philippines FDA Approvals